Immunovant IMVT
NASDAQ IMVT
$28.31 -0.28 (-1.00%)
As of: Oct 21, 2026 · 3:45 PM EDT

Immunovant (IMVT) Total Liabilities (2018 - 2026)

Updated

Immunovant (IMVT) recorded Total Liabilities of $117.1 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 121.4% from $52.9 million a year earlier and up 12.1% from the prior quarter.

Analysis

Immunovant (IMVT) Total Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Total Liabilities of $104.42 million, up 51.8% from FY2025.

  • Annual Total Liabilities has increased for three straight fiscal years, with a five-year compound annual growth rate of 37.8% (FY2021 to FY2026).
  • Across earlier fiscal years, Total Liabilities came in at $68.78 million in FY2025 (+41.5%), $48.61 million in FY2024 (+12.1%), $43.34 million in FY2023 (-5.2%) and $45.74 million in FY2022 (+117.7%).
  • The fiscal Q1 2027 figure is the highest quarterly Total Liabilities since fiscal Q2 2020.
  • On a year-over-year basis, Total Liabilities rose in six of the last eight quarters, with growth averaging 50.3%.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 131.7% in fiscal Q1 2024, against a decline of 22.8% in fiscal Q3 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $104.42 million (Q4 2026), $66.26 million (Q3 2026) and $63.25 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 116.09 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 141.05 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 65.46 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn 37.53 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 115.64 Bn
10 Immunovant 5.82 Bn 2.60 Bn - 117.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.10 Mn
Mar 31, 2026 104.42 Mn
Dec 31, 2025 66.26 Mn
Sep 30, 2025 63.25 Mn
Jun 30, 2025 52.90 Mn
Mar 31, 2025 68.78 Mn
Dec 31, 2024 68.32 Mn
Sep 30, 2024 66.65 Mn
Jun 30, 2024 45.02 Mn
Mar 31, 2024 48.61 Mn
Dec 31, 2023 32.10 Mn
Sep 30, 2023 40.26 Mn
Jun 30, 2023 51.36 Mn
Mar 31, 2023 43.34 Mn
Dec 31, 2022 41.57 Mn
Sep 30, 2022 32.40 Mn
Jun 30, 2022 22.16 Mn
Mar 31, 2022 45.74 Mn
Dec 31, 2021 38.03 Mn
Sep 30, 2021 30.34 Mn
API Access

Immunovant Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=IMVT&period=max&api_key=YOUR_API_KEY